about
PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical modelsPeritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugsDrug conjugation to hyaluronan widens therapeutic indications for ovarian cancerA BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers.Site-Specific Transglutaminase-Mediated Conjugation of Interferon α-2b at Glutamine or Lysine Residues.A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer.Design, synthesis and evaluation of biotin decorated inulin-based polymeric micelles as long-circulating nanocarriers for targeted drug delivery.Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.
P50
Q27339832-46ADC6BE-D0D9-4571-97D0-E681DD5790ECQ28544821-6B480164-463D-40A3-9C4B-7A1728DEA7E1Q28648402-352A1D4F-5FEA-4549-9147-B7DF7F7C28CAQ33632095-5755EF3D-ED51-4E26-A584-F90BD9093349Q38714992-9136E0FC-E770-4665-8622-75A43FFE66A7Q40509438-B4E474A0-1DBF-401A-AFF6-CB87A495C51CQ40676079-5F6411AF-733F-4BE4-81B2-11D14224CC70Q50937400-E3D1BD16-2D20-4192-B718-B1A6F0D9FCAFQ52641750-59269139-6D96-4C27-B7BA-E8ABF66FEB05
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Isabella Monia Montagner
@ast
Isabella Monia Montagner
@en
Isabella Monia Montagner
@es
Isabella Monia Montagner
@nl
type
label
Isabella Monia Montagner
@ast
Isabella Monia Montagner
@en
Isabella Monia Montagner
@es
Isabella Monia Montagner
@nl
prefLabel
Isabella Monia Montagner
@ast
Isabella Monia Montagner
@en
Isabella Monia Montagner
@es
Isabella Monia Montagner
@nl
P106
P1153
42962146300
P21
P31
P496
0000-0002-5778-2221